Morgan Stanley Sees 70% Upside In GW Pharma
June 28, 2016 at 08:26 AM EDT
GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH) has announced positive top-line results from the first Phase 3 trial of Epidiolex in ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.